Clinical Trials Sponsored by OptiNose AS

Total 362 results

OptiNose AS
University of Oslo

Completed

Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults

Healthy Male Adults

Norway
OptiNose AS
University of Oslo; Oslo University Hospital

Completed

Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Adults With Autism Spectrum Disorder

Autism Spectrum Disorder

Norway
Optinose US Inc.

Terminated

A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19

Covid19

Mexico
Optinose US Inc.

Completed

12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device

Nasal Polyps

United States
Optinose US Inc.

Completed

A Study to Compare the Bioavailability Intranasal Administration of 200 and 400 µg or 400 µg Alone of OPTINOSE™ FLUTICASONE With 440 µg of Flovent® HFA (Fluticasone Propionate) Inhalation Aerosol (Part 2)

Mild to Moderate Asthma

Ireland
Optinose US Inc.

Recruiting

OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

Bilateral Nasal Polyposis

United States
Optinose US Inc.

Completed

Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps

Chronic Rhinosinusitis

United States, United Kingdom, Bulgaria, Canada, Georgia, Poland, Russian Federation, Sweden
Optinose US Inc.

Completed

Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device

Bilateral Nasal Polyposis

United States
Optinose US Inc.

Completed

Bioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX® in Healthy Subjects

Migraine

United States
Optinose US Inc.

Completed

Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps

Chronic Rhinosinusitis

United States, Australia, Poland, New Zealand, Spain, Georgia, United Kingdom, Bulgaria, Czechia, Romania
Optinose US Inc.

Completed

Efficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video

Nasal Polyposis

United States
Optinose US Inc.

Completed

Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety

Bilateral Nasal Polyposis

United States, Canada
Optinose US Inc.

Completed

Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps

Chronic Sinusitis With or Without Nasal Polyps

United States
Optinose US Inc.

Completed

Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine

Migraine Headache

United States
Epax Norway AS
Møreforsking AS

Unknown

Study of the Effect of Different Fish Oils on Omega-3 Index (CetoIndex) (CetoIndex)

Healthy Volunteers

Norway
Epax Norway AS
Møreforsking AS

Recruiting

Nutritional Study of Fish Oil in Skin Quality in Healthy Women (OPTIHUD)

Skin Health

Norway
Pacertool AS

Not yet recruiting

Pacertool Early Feasibility Study - Safety and Performance

Heart Failure With Reduced Ejection Fraction | Dyssynchrony | Medical Device Performance

Georgia
Serodus AS

Recruiting

SER150 vs Placebo in Diabetic Kidney Disease

Diabetic Kidney Disease

Australia, New Zealand
CardioMech AS

Recruiting

EFS of the CardioMech MVRS

Mitral Regurgitation

United States
Labrida AS

Completed

Treatment of Advanced Periodontitis Using an Oscillating Chitosan Device Versus Regular Curettes Alone

Periodontal Diseases

Norway, Turkey
Revmatismesykehuset AS

Completed

Effect of a Thin Customized Insole in RA

Rheumatoid Arthritis
AlgiPharma AS

Completed

A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis (OligoG)

Cystic Fibrosis

United Kingdom, Ireland
Marealis AS

Completed

Antihypertensive Effect and Safety of Peptides Derived From Coldwater Shrimp (MARE)

Hypertension | Blood Pressure

Finland
Revmatismesykehuset AS

Completed

Effect of One Week Self-management Program in Patients With Fibromyalgia

Fibromyalgia

Norway
Picterus AS

Recruiting

Clinical Validation of the Screening Tool Picterus JP Using Different Smartphones (allphones)

Neonatal Jaundice

Norway
SonoClear AS

Recruiting

SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue

Glioblastoma | High Grade Glioma | Low-grade Glioma | Brain Tumour

Germany, Slovakia, Italy
Oncoinvent AS

Active, not recruiting

Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC

Peritoneal Carcinoma | Colorectal Carcinoma

Norway, Sweden
HoloCare AS

Completed

HS2 US Liver Reader Study

Reader Study

United States
Otivio AS

Enrolling by invitation

Performance and Long-term Safety of FlowOx2.0™, Multiple Sclerosis, Spasticity and Pain

Pain | Multiple Sclerosis | Spasticity, Muscle

Norway
BASF AS

Unknown

Hepaxa Management of Non-alcoholic Fatty Liver Disease

NASH - Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease | Non Alcoholic Fatty Liver

United States
AlgiPharma AS

Completed

A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection (SMR-2591)

Cystic Fibrosis | Burkholderia Infection

Germany
Blueskin AS

Recruiting

A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo (Derma-001)

Psoriasis | Atopic Dermatitis | Vitiligo | Alopecia Areata

Denmark
Biomad AS

Not yet recruiting

Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3

Sars-cov-2

Iraq
Oncoinvent AS

Active, not recruiting

Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis

Ovarian Cancer | Peritoneal Carcinomatosis

Belgium, Spain, Norway
Otivio AS

Active, not recruiting

Performance and Long-term Safety of FlowOx2.0™ in Patients With Multiple Sclerosis - Impact on Spasticity and Pain (FO-NP002)

Multiple Sclerosis | Spasticity, Muscle | Pain, Chronic

Sweden
Labrida AS

Completed

Treatment of Mild to Moderate Peri-implantitis Using an Oscillating Chitosan Device

Peri-Implantitis

Norway, Sweden
Smartfish AS

Completed

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in COPD Cachexia

Cachexia | COPD

Sweden
Biovotec AS

Completed

DermaRep™ Device in the Treatment of Venous Leg Ulcers (DermaRep™)

Venous Leg Ulcer

United Kingdom
Smartfish AS

Completed

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia

NSCLC | Cachexia

Italy, Sweden, Croatia, Slovakia
Ayanda AS

Completed

Bioavailability Study of Long Chain Omega-3 Fatty Acids From a Gastric Stable Emulsion

Healthy

Norway
SantoSolve AS

Completed

2PX (Topical Strontium Chloride Hexahydrate) in Patients With Post-Amputation Stump Pain.

Pain | Amputation Stumps

Norway
Ferrosan AS

Completed

Glucosamine Sulphate, Ginger, Ginger-Avocado-Soya and Ginger-Ibuprofen for Chronic Back Pain

Back Pain

Denmark
Smerud Medical Research International AS
SantoSolve AS

Unknown

Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain

Stump Pain

Denmark, Germany, Norway, Russian Federation, United Kingdom
Smerud Medical Research International AS
SantoSolve AS

Unknown

A Study of the Efficacy and Safety of 2PX in Patients With Pain Due to Osteoarthritis of the Knee

Pain | Osteoarthritis

United Kingdom, Finland, Poland, Russian Federation
AlgiPharma AS
Smerud Medical Research International AS

Completed

Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis

Cystic Fibrosis

United Kingdom
AlgiPharma AS
Eurostars; Smerud Medical Research International AS

Completed

A Phase IIb Study of OligoG in Subjects With Cystic Fibrosis (SMR-2984)

Cystic Fibrosis

United Kingdom, Denmark, Norway, Germany, Sweden
PCI Biotech AS

Terminated

PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer (RELEASE)

Cholangiocarcinoma

United States, Spain, Belgium, Germany, Italy, Denmark, Finland, France, Korea, Republic of, Norway, Poland, Sweden, Taiwan, Ukraine
SoftOx Solutions AS

Completed

Safety and Tolerability of Single and Multiple Doses of SoftOx Biofilm Eradicator (SBE) in Chronic Leg Wounds

Venous Leg Ulcer | Chronic Leg Ulcer

Denmark
SoftOx Solutions AS

Completed

Safety of Ascending Single and Multiple Doses of Nebulised SoftOx Inhalation Solution in Healthy Subjects

Healthy Volunteers | Safety

Denmark
PCI Biotech AS

Completed

A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas

Cholangiocarcinoma

Germany, France, Norway, United Kingdom

3

Subscribe